Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) and Advanced Fibrosis in Type 2 Diabetes Mellitus Patients. Pakistan Journal of Medical & Cardiological Review, [S. l.], v. 5, n. 1, p. 163–174, 2026. DOI: 10.5281/zenodo.18345788. Disponível em: https://pakjmcr.com/index.php/1/article/view/492. Acesso em: 31 jul. 2026.